Derivative Instruments (Tables)

9 Months Ended

Sep. 30, 2012

Derivative Instruments [Abstract]

Derivative instruments measured at fair value

	Asset (Liability) as of September 30,					(Liability) as of December 31,
	2012					2011
						(unaudited)
	Notional Amount		Fair Value			Notional Amount		Fair Value
Forward foreign exchange contracts included in accrued and other current liabilities	$	15,378	$	(350	)	$	20,135	$	(631	)
Forward foreign exchange contracts included in prepaid expenses and other current assets	$	12,446	$	269			—		—

Gains (losses) on derivative instruments and their classification on the condensed consolidated statement of operations

	For the three  months ended September 30,						For the nine  months ended September 30,
	2012			2011			2012			2011
Foreign Exchange Forward Contract Derivatives in cash flow hedging relationships:
Gains recognized in OCI (a)	$	223		$	—			223		$	—
Losses recognized in OCI (a)		(115	)		(204	)		(225	)		(138	)
Gains recognized from accumulated OCI into net loss (b)		—			139			—			674
Losses recognized from accumulated OCI into net loss (b)		(283	)		—			(464	)		—
Gains recognized in net loss (c)		—			—			—			49
Losses recognized in net loss (c)		—			(6	)		(5	)		—
Foreign Exchange Forward Contract Derivatives not designated as hedging relationships:
Gains recognized in net loss (d)		47			—			117			—
Losses recognized in net loss (d)	$	—		$	—		$	(17	)	$	—

(a) Net change in the fair value of the effective portion classified in other comprehensive income (loss) (“OCI”).

(b) Effective portion of cash flow hedges reclassified from accumulated other comprehensive income (loss) into net loss, of which $(17) and $(266) were recognized within cost of sales and operating expenses, respectively, for the three months ended September 30, 2012 and $(31) and $(433) were recognized within cost of sales and operating expenses for the nine months ended September 30, 2012. $11 and $128 were recognized within cost of sales and operating expenses, respectively for the three months ended September 30, 2011 and $53 and $621 were recognized within cost of sales and operating expenses, respectively, for the nine months ended September 30, 2011. All amounts are reflected with the respective condensed consolidated statement of operations.

(c) Ineffective portion and amount excluded from effectiveness testing classified in other income (expense), net.

(d) Classified in other income (expense), net.